Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2011 Filed Dec 22, 2011 21:47 UTC |
REASON J PAULDirector
|
Exercise / conversionCommon Stock | 16,000 | $56.30 | $900,800.00 |
DisclosureSEC source: 0001127602-11-033106 · form4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:49 UTC |
BIONDI FRANKDirector
|
GrantDividend Equivalent · Derivative | 45.736 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031939 · form4.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93.7881 Underlying: Common Stock · 45.736 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:51 UTC |
COFFMAN VANCE DDirector
|
GrantDividend Equivalent · Derivative | 22.2282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031942 · form4.xml · derivative · entry 1 COFFMAN VANCE D · CIK 0001193998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52.9366 Underlying: Common Stock · 22.2282 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:55 UTC |
de Carbonnel FrancoisDirector
|
GrantDividend Equivalent · Derivative | 9.55 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031944 · form4.xml · derivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19.5836 Underlying: Common Stock · 9.55 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:59 UTC |
HERRINGER FRANK CDirector
|
GrantDividend Equivalent · Derivative | 52.1685 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031946 · form4.xml · derivative · entry 1 HERRINGER FRANK C · CIK 0001171694 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106.9788 Underlying: Common Stock · 52.1685 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 13, 2011 00:02 UTC |
OMENN GILBERT SDirector
|
GrantDividend Equivalent · Derivative | 20.984 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031948 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43.0306 Underlying: Common Stock · 20.984 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 13, 2011 00:06 UTC |
HENDERSON REBECCA MDirector
|
GrantDividend Equivalent · Derivative | 8.2442 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031951 · form4.xml · derivative · entry 1 HENDERSON REBECCA M · CIK 0001254748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16.9059 Underlying: Common Stock · 8.2442 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 13, 2011 00:10 UTC |
REASON J PAULDirector
|
GrantDividend Equivalent · Derivative | 29.2282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031953 · form4.xml · derivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59.9366 Underlying: Common Stock · 29.2282 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 08, 2011 Filed Dec 13, 2011 00:13 UTC |
SCHAEFFER LEONARD DDirector
|
GrantDividend Equivalent · Derivative | 14.3491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031955 · form4.xml · derivative · entry 1 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29.4249 Underlying: Common Stock · 14.3491 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 18, 2011 Filed Jan 9, 2012 23:35 UTC |
MCNAMEE BRIAN MSVP, Human Resources
|
GiftCommon Stock | 1,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-001375 · form5.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,855 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| November 08, 2011 Filed Nov 10, 2011 01:57 UTC |
BONANNI FABRIZIOEVP, Operations
|
SaleCommon Stock | 10,000 | $58.12 | $581,233.00 |
DisclosureSEC source: 0001127602-11-029177 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 64,194 F1 · price: The price reported is an average price. The prices ranged from $58.12 to $58.15 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| November 08, 2011 Filed Nov 10, 2011 02:01 UTC |
SHARER KEVIN WDirector · Chairman of the Board and CEO
|
SaleCommon Stock | 52,500 | $58.22 | $3,056,607.75 |
DisclosureSEC source: 0001127602-11-029179 · form4.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Living Trust Disclosed balance after: 172,222 F1 · price: The price reported is an average price. The prices ranged from $58.02 to $58.42 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| November 08, 2011 Filed Nov 10, 2011 02:04 UTC |
RICHO ANNASVP & CCO
|
SaleCommon Stock | 1,500 | $58.07 | $87,105.00 |
DisclosureSEC source: 0001127602-11-029181 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 3,743 Read SEC document |
| October 28, 2011 Filed Oct 31, 2011 23:59 UTC |
Peacock Jonathan MEVP & CFO
|
Tax withholdingCommon Stock | 10,427 | $58.06 | $605,391.62 |
DisclosureSEC source: 0001127602-11-028022 · form4.xml · nonDerivative · entry 1 Peacock Jonathan M · CIK 0001500241 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,373 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 75,000 RSUs which vest in three equal annual installments of 25,000 each commencing 10/28/2012; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| October 27, 2011 Filed Oct 28, 2011 21:31 UTC |
HOOPER ANTHONY CEVP, Global Commercial Ops.
|
GrantCommon Stock | 45,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-027872 · form4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,238 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest on the following schedule: 22,619 RSUs vest on 3/2/2012; 15,380 RSUs vest in two equal annual installments of 7,690 on 3/2/2013 and 3/2/2014; and 7,239 RSUs vest on 3/2/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:05 UTC |
BIONDI FRANKDirector
|
GrantDividend Equivalent · Derivative | 48.0521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025052 · form4.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48.0521 Underlying: Common Stock · 48.0521 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:11 UTC |
HENDERSON REBECCA MDirector
|
GrantDividend Equivalent · Derivative | 8.6617 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025056 · form4.xml · derivative · entry 1 HENDERSON REBECCA M · CIK 0001254748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8.6617 Underlying: Common Stock · 8.6617 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:08 UTC |
COFFMAN VANCE DDirector
|
GrantDividend Equivalent · Derivative | 30.7084 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025054 · form4.xml · derivative · entry 1 COFFMAN VANCE D · CIK 0001193998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30.7084 Underlying: Common Stock · 30.7084 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:14 UTC |
HERRINGER FRANK CDirector
|
GrantDividend Equivalent · Derivative | 54.8103 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025058 · form4.xml · derivative · entry 1 HERRINGER FRANK C · CIK 0001171694 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54.8103 Underlying: Common Stock · 54.8103 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:21 UTC |
de Carbonnel FrancoisDirector
|
GrantDividend Equivalent · Derivative | 10.0336 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025061 · form4.xml · derivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10.0336 Underlying: Common Stock · 10.0336 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:33 UTC |
OMENN GILBERT SDirector
|
GrantDividend Equivalent · Derivative | 22.0466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025063 · form4.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22.0466 Underlying: Common Stock · 22.0466 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:36 UTC |
REASON J PAULDirector
|
GrantDividend Equivalent · Derivative | 30.7084 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025065 · form4.xml · derivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30.7084 Underlying: Common Stock · 30.7084 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:43 UTC |
SCHAEFFER LEONARD DDirector
|
GrantDividend Equivalent · Derivative | 15.0758 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025067 · form4.xml · derivative · entry 1 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15.0758 Underlying: Common Stock · 15.0758 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 07, 2011 Filed Sep 8, 2011 17:37 UTC |
MCNAMEE BRIAN MSVP, Human Resources
|
SaleCommon Stock | 1,000 | $54.73 | $54,730.00 |
DisclosureSEC source: 0001127602-11-024955 · form4.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,847 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| August 31, 2011 Filed Sep 1, 2011 18:52 UTC |
SCOTT DAVID JSVP, Gen. Counsel & Secy.
|
SaleCommon Stock | 20,000 | $55.44 | $1,108,828.00 |
DisclosureSEC source: 0001127602-11-024630 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,190 F1 · price: The price reported is an average price. The prices ranged from $55.43 to $55.46 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| August 15, 2011 Filed Aug 15, 2011 22:50 UTC |
BEIER DAVID WSVP Global Govt & Corp Affairs
|
SaleCommon Stock | 15,000 | $51.56 | $773,470.50 |
DisclosureSEC source: 0001127602-11-023655 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · price: The price reported is an average price. The prices ranged from $51.68 to $50.18 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| August 04, 2011 Filed Aug 8, 2011 21:21 UTC |
de Carbonnel FrancoisDirector
|
PurchaseCommon Stock | 1,000 | $53.02 | $53,019.50 |
DisclosureSEC source: 0001127602-11-023000 · form4.xml · nonDerivative · entry 1 de Carbonnel Francois · CIK 0001447121 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,321 F1 · price: The price reported is an average price. The prices ranged from $53.005 to $53.03 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: Includes 1,828 Restricted Stock Units ("RSUs") which fully vest on April 25, 2012. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
Exercise / conversionNqso (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · derivative · entry 11 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
Exercise / conversionNqso (Right to Buy) · Derivative | 2,950 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · derivative · entry 10 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950 Underlying: Common Stock · 2,950 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
SaleCommon Stock | 20,000 | $55.01 | $1,100,200.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 8 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,849 F3 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 843 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 20,000 RSUs which fully vest on 10/28/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F4 · balance_after: These shares include 1,306 shares of common stock acquired under the Company's Employee Stock Purchase Plan (ESPP). 450 shares were acquired under the Company's ESPP on June 15, 2011. The additional 856 shares of common stock under the ESPP had previously been reported and incorrectly attributed to the reporting person's Family Trust. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
SaleCommon Stock | 2,950 | $55.05 | $162,397.50 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 7 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,543 Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
Exercise / conversionCommon Stock | 20,000 | $50.44 | $1,008,800.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 6 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
Exercise / conversionCommon Stock | 2,950 | $42.13 | $124,283.50 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 5 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
SaleCommon Stock | 2,000 | $55.01 | $110,023.80 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 5,243 F2 · price: The price reported is an average price. The prices ranged from $54.97 to $55.05 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 31, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
GiftCommon Stock | 1,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 3 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 7,243 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| July 31, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
GiftCommon Stock | 1,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 2 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,543 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| July 31, 2011 Filed Aug 2, 2011 23:08 UTC |
RICHO ANNASVP & CCO
|
Tax withholdingCommon Stock | 918 | $54.70 | $50,214.60 |
DisclosureSEC source: 0001127602-11-022632 · form4.xml · nonDerivative · entry 1 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,125 Read SEC document |
| July 31, 2011 Filed Aug 3, 2011 00:59 UTC |
Dittrich Thomas J.W.VP, Finance & CAO
|
Tax withholdingCommon Stock | 679 | $54.70 | $37,141.30 |
DisclosureSEC source: 0001127602-11-022646 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,952 F1 · balance_after: These shares include the corrected beneficial ownership total, as amended by the Form 3/A filed on August 2, 2011. The shares also include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| May 31, 2011 Filed Feb 14, 2012 01:12 UTC |
BIONDI FRANKDirector
|
GiftNqso (Right to Buy) · Derivative | 1,863.2 | $50.44 Strike: $50.44 | $93,979.81 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 16 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,863.2 shares Expires 2016-04-28 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| May 31, 2011 Filed Feb 14, 2012 01:12 UTC |
BIONDI FRANKDirector
|
GiftNqso (Right to Buy) · Derivative | 1,863.2 | $50.44 Strike: $50.44 | $93,979.81 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 15 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 26 Disclosed balance after: 0 Underlying: Common Stock · 1,863.2 shares Expires 2016-04-28 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:06 UTC |
BEIER DAVID WSVP Global Govt & Corp Affairs
|
Tax withholdingCommon Stock | 1,248 | $57.14 | $71,310.72 |
DisclosureSEC source: 0001127602-11-014432 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,902 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC |
BONANNI FABRIZIOEVP, Operations
|
GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 74,194 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC |
BONANNI FABRIZIOEVP, Operations
|
GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,800 F1 · shares: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 40,000 RSUs which vest fully on 12/31/2013; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:09 UTC |
BONANNI FABRIZIOEVP, Operations
|
Tax withholdingCommon Stock | 1,357 | $57.14 | $77,538.98 |
DisclosureSEC source: 0001127602-11-014435 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,443 Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:12 UTC |
Bradway Robert APresident and COO
|
Tax withholdingCommon Stock | 1,401 | $57.14 | $80,053.14 |
DisclosureSEC source: 0001127602-11-014440 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,489 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 4,500 RSUs which vest in three equal annual installments of 1,500 each commencing 4/26/2012; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:15 UTC |
MCNAMEE BRIAN MSVP, Human Resources
|
Tax withholdingCommon Stock | 1,331 | $57.14 | $76,053.34 |
DisclosureSEC source: 0001127602-11-014444 · form4.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,847 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:18 UTC |
PERLMUTTER ROGER MEVP, Research & Development
|
Tax withholdingCommon Stock | 1,357 | $57.14 | $77,538.98 |
DisclosureSEC source: 0001127602-11-014447 · form4.xml · nonDerivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · EVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,031 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; and 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:20 UTC |
RICHO ANNASVP & CCO
|
GiftCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014451 · form4.xml · nonDerivative · entry 6 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust Disclosed balance after: 6,517 F1 · shares: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:20 UTC |
RICHO ANNASVP & CCO
|
GiftCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-014451 · form4.xml · nonDerivative · entry 5 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,043 F1 · shares: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,500 RSUs which fully vest on 7/31/2011; 843 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 20,000 RSUs which fully vest on 10/28/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:20 UTC |
RICHO ANNASVP & CCO
|
Tax withholdingCommon Stock | 310 | $57.14 | $17,713.40 |
DisclosureSEC source: 0001127602-11-014451 · form4.xml · nonDerivative · entry 4 RICHO ANNA · CIK 0001199306 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,576 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.